Label claims for a peptide collagen body oil are governed by a critical regulatory distinction: in the United States and European Union alike, a product is either a cosmetic (claims appearance or sensory benefit) or a drug/medicinal product (claims to treat, cure, or alter body structure or function). Crossing the cosmetic-drug line without the appropriate pharmaceutical authorization is a serious regulatory violation.
In the U.S. under FDA rules, permissible cosmetic claims for a peptide body oil include: 'improves the appearance of skin firmness,' 'helps skin look smoother,' 'skin appears more youthful,' 'visibly reduces the look of fine lines,' and 'deeply moisturizing.' Impermissible (drug) claims include: 'rebuilds collagen,' 'stimulates collagen synthesis,' 'repairs skin at the cellular level,' 'increases skin elasticity by X%,' or any claim that implies the product changes skin structure rather than appearance.
The phrase 'boosts collagen' is a gray zone and has drawn FDA warning letters in the past. Conservative brands use 'supports the look of skin's natural firmness' instead.
In the EU under Regulation 1223/2009, the same appearance-versus-function line applies, enforced by the national competent authority of each member state. The EU additionally has a Common Criteria Regulation (EU 2023/1545) for cosmetic claims that requires claims to be truthful, evidenced, honest, fair, and non-misleading. If you make a claim like 'clinically proven to firm skin,' you must have the clinical study on file and it must use the finished marketed product — not just an ingredient-level study from the peptide supplier.
For hydrolyzed collagen specifically: the ingredient itself cannot penetrate the dermis in meaningful quantity at cosmetic use levels — its mechanism is surface film-forming and moisture retention. Your claims should reflect that reality. Overpromising on collagen 'penetration' or 'integration into skin' will attract regulatory attention and may invite consumer litigation.
Peptide mechanism claims sourced from supplier technical data sheets (e.g., 'palmitoyl tripeptide-1 supports skin's collagen network') can generally be cited as ingredient-level background in marketing copy, but the finished-product claim must still reflect observable appearance benefit, not physiological change.
For U.S. compliance, review your full claim set against FDA's cosmetic claim guidance and the FTC's truth-in-advertising requirements before launch. For EU, your Responsible Person and safety assessor should review all claims as part of the CPNP process. AJ Cosmo Labs connects founders with regulatory consultants and safety assessors who can review your claim set before you commit to packaging print runs.
Ingredients in this answer: Hydrolyzed Collagen
Read the full guide on Private Label Peptide Collagen Body Oil Manufacturer Low MOQ →